MedTrace Logo

Venous Thromboembolic Complications in Ovarian Cancer

NCT02480790 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2018-10-05

No results posted yet for this study

Summary

Objectives of the study are: To estimate the incidence of venous thromboembolism (VTE) in a cohort of women with suspected ovarian cancer and evaluate changes in the coagulation system in case of benign or malignant disease. The impact of changes in the coagulation system on disease prognosis will be evaluated.

Conditions

  • Venous Thromboembolism
  • Ovarian Neoplasms
  • Ovarian Cancer
  • Deep Vein Thrombosis
  • Lung Embolism

Sponsors & Collaborators

  • Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery

    lead OTHER

Principal Investigators

  • Ole Thorlacius-Ussing, MD, DMSc · Department of Gastrointestinal Surgery, Aalborg University Hospital

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-05-31
Completion
2019-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02480790 on ClinicalTrials.gov